U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07937657) titled 'A Study to Evaluate the Safety and Pain Relief of MAX-001 After Surgical Removal of Wisdom Teeth' on Nov. 09.

Brief Summary: This is a single center, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of MAX-001 in participants with post-operative dental pain after wisdom teeth removal.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Impacted Third Molar Tooth Tooth Extraction Status Nos

Intervention: DRUG: MAX-001

30 mg oral tablets

DRUG: Placebo

matching placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Maxona Pharmaceuticals, Inc.

Published b...